Search Results 911-920 of 18600 for Relapse

  1. A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant - Mayo Clinic

    ... relapse based on the presence of pre-transplant risk factors. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  2. Medical Research & Education - Mayo Clinic News Network

    Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...

  3. Efficacy And Safety Of Nemtabrutinib (MK-1026) In Participants With Hematologic Malignancies (MK-1026-003) - Mayo Clinic

    ... relapsed or refractory following at least 1 line of prior therapy * Part 2 Cohort J: CLL/SLL participants whose disease relapsed or was refractory to prior ...

  4. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics Center

    Root Cause of Multiple Myeloma Relapse Revealed. Related Articles. Mayo Clinic Minute: How liver transplant is transforming care for patients with advanced ...

  5. Dr. Dean Wingerchuk Archives - Mayo Clinic News Network

    ... relapse, disability can worsen. It affects up to 10 in 100,000 people. Currently, the immunosuppressive therapies used to prevent neuromyelitis optica relapses ...

  6. Publications - Taimur Sher, M.B.B.S., M.D. - Mayo Clinic

    Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma. Anticancer Drugs. 2024 Jan 1; 35 (1): ...

  7. Clinical trials - Oncology (Medical)

    NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to ...

  8. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...

  9. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...

  10. Hematology - Clinical trials

    The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...